{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/12/3310975/0/en/MBX-Biosciences-Announces-One-Year-Data-Demonstrating-Sustained-Benefit-of-Once-Weekly-Canvuparatide-as-a-Potential-PTH-Replacement-Therapy-in-Chronic-Hypoparathyroidism.html", "message": "News view counter 795704 successfully enlarged"}